Outlook Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+7.2% +$1M
$18M
Current Assets↑+9.6% +$1M
$17M
Cash & Equivalents↑+52.2% +$3M
$9M
Receivables
$115K
Inventory↑+11.2% +$349K
$3M
Net PPE
—
Total Liabilities↓-15.6% -$11M
$57M
Current Liabilities↑+1.7% +$819K
$49M
Account Payables↓-40.0% -$5M
$7M
Long-Term Debt
—
Short-Term Debt
—
Stockholders Equity↑+23.3% +$12M
$-39M
Retained Earnings↓-19.6% -$103M
$-629M
Operating Lease ROU Asset↓-19.2% -$50K
$212K
Operating Lease Liability↓-18.4% -$53K
$233K
Finance Lease ROU Asset
—
Gross PP&E
—
Accumulated Depreciation
—
Inventory Raw Materials
$2M
Inventory WIP
$1M
Inventory Finished Goods
$30K
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Debt Due >Y5
—
Total Debt Carrying Amount
—